Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial
口服阿扎胞苷治疗缓解期急性髓系白血病患者的不良事件管理:来自 QUAZAR AML-001 3 期随机试验的经验
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-021-01142-x
Ravandi, Farhad; Roboz, Gail J; Wei, Andrew H; Döhner, Hartmut; Pocock, Christopher; Selleslag, Dominik; Montesinos, Pau; Sayar, Hamid; Musso, Maurizio; Figuera-Alvarez, Angela; Safah, Hana; Tse, William; Sohn, Sang Kyun; Hiwase, Devendra; Chevassut, Timothy; Pierdomenico, Francesca; La Torre, Ignazia; Skikne, Barry; Bailey, Rochelle; Zhong, Jianhua; Beach, C L; Dombret, Herve